Biosplice Therapeutics, Inc.
Clinical trials sponsored by Biosplice Therapeutics, Inc., explained in plain language.
-
One-Shot knee injection tested as potential Game-Changer for arthritis pain
Disease control CompletedThis study tested whether a single injection of an experimental drug called lorecivivint could reduce pain and improve function in people with moderate-to-severe knee osteoarthritis. Nearly 500 adults received either the drug or a placebo injection into their most painful knee an…
Phase: PHASE3 • Sponsor: Biosplice Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New knee injection aims to tackle arthritis pain and bone loss
Disease control CompletedThis study tested the safety of an experimental drug called SM04690, given as two injections into the knee about six months apart, for people with moderate to severe knee osteoarthritis pain. The main goal was to see if the injections were safe and how they affected bone density …
Phase: PHASE2 • Sponsor: Biosplice Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
One-Shot knee injection tested for lasting arthritis relief
Disease control CompletedThis completed Phase 3 trial tested whether a single injection of an experimental drug, lorecivivint, could safely reduce pain and improve function in adults with moderate-to-severe knee osteoarthritis. Over 500 participants received either the drug or a placebo injection into th…
Phase: PHASE3 • Sponsor: Biosplice Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC